Noramco Invests $25M in Halo Pharma’s Whippany Facility for Sterile Injectable Manufacturing

Noramco Invests $25M in Halo Pharma’s Whippany Facility for Sterile Injectable Manufacturing The Noramco Group, a North American provider of integrated API and drug product supply chain services, has announced a $25 million investment in its Halo Pharma facility in…










